Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine and Vinorelbine in Elderly Metastatic Breast Cancer
NCT00003902Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Mar 1999
- Primary completion
- Dec 2004
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, vinorelbine in breast cancer, sponsored by Swiss Group for Clinical Cancer Research. Started Mar 1999; status: completed.
02
Drugs
capecitabinevinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003902.